Annual Total Debt
$18.08 B
-$2.07 B-10.29%
December 31, 2024
Summary
- As of February 25, 2025, TEVA annual total debt is $18.08 billion, with the most recent change of -$2.07 billion (-10.29%) on December 31, 2024.
- During the last 3 years, TEVA annual total debt has fallen by -$5.38 billion (-22.93%).
- TEVA annual total debt is now -49.50% below its all-time high of $35.80 billion, reached on December 31, 2016.
Performance
TEVA Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$18.08 B
-$1.20 B-6.20%
December 31, 2024
Summary
- As of February 25, 2025, TEVA quarterly total debt is $18.08 billion, with the most recent change of -$1.20 billion (-6.20%) on December 31, 2024.
- Over the past year, TEVA quarterly total debt has stayed the same.
- TEVA quarterly total debt is now -50.95% below its all-time high of $36.85 billion, reached on September 30, 2016.
Performance
TEVA Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
TEVA Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.3% | 0.0% |
| 3 y3 years | -22.9% | 0.0% |
| 5 y5 years | -33.9% | 0.0% |
TEVA Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.9% | at low | -22.9% | at low |
| 5 y | 5-year | -33.9% | at low | -33.9% | at low |
| alltime | all time | -49.5% | >+9999.0% | -51.0% | -100.0% |
Teva Pharmaceutical Industries Limited Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $18.08 B(-10.3%) | $18.08 B(-6.2%) |
| Sep 2024 | - | $19.27 B(+1.9%) |
| Jun 2024 | - | $18.92 B(-5.1%) |
| Mar 2024 | - | $19.94 B(-1.1%) |
| Dec 2023 | $20.15 B(-6.5%) | $20.15 B(-0.7%) |
| Sep 2023 | - | $20.30 B(-3.4%) |
| Jun 2023 | - | $21.02 B(-0.1%) |
| Mar 2023 | - | $21.04 B(-2.4%) |
| Dec 2022 | $21.56 B(-8.1%) | $21.56 B(-0.3%) |
| Sep 2022 | - | $21.62 B(-3.7%) |
| Jun 2022 | - | $22.45 B(-3.7%) |
| Mar 2022 | - | $23.31 B(-0.6%) |
| Dec 2021 | $23.46 B(-11.1%) | $23.46 B(-2.9%) |
| Sep 2021 | - | $24.17 B(-5.5%) |
| Jun 2021 | - | $25.58 B(+0.6%) |
| Mar 2021 | - | $25.43 B(-3.7%) |
| Dec 2020 | $26.40 B(-3.5%) | $26.40 B(+1.2%) |
| Sep 2020 | - | $26.09 B(-2.2%) |
| Jun 2020 | - | $26.68 B(+0.6%) |
| Mar 2020 | - | $26.51 B(-3.0%) |
| Dec 2019 | $27.34 B(-5.4%) | $27.34 B(+0.0%) |
| Sep 2019 | - | $27.34 B(-6.2%) |
| Jun 2019 | - | $29.15 B(+0.4%) |
| Mar 2019 | - | $29.05 B(+0.5%) |
| Dec 2018 | $28.92 B(-11.0%) | $28.92 B(-1.9%) |
| Sep 2018 | - | $29.49 B(-2.5%) |
| Jun 2018 | - | $30.24 B(-1.7%) |
| Mar 2018 | - | $30.75 B(-5.3%) |
| Dec 2017 | $32.48 B(-9.3%) | $32.48 B(-6.4%) |
| Sep 2017 | - | $34.70 B(-1.0%) |
| Jun 2017 | - | $35.05 B(+1.2%) |
| Mar 2017 | - | $34.64 B(-3.3%) |
| Dec 2016 | $35.80 B(+260.1%) | $35.80 B(-2.9%) |
| Sep 2016 | - | $36.85 B(+237.6%) |
| Jun 2016 | - | $10.92 B(+7.0%) |
| Mar 2016 | - | $10.20 B(+2.6%) |
| Dec 2015 | $9.94 B(-3.7%) | $9.94 B(-14.8%) |
| Sep 2015 | - | $11.66 B(-6.8%) |
| Jun 2015 | - | $12.52 B(+13.6%) |
| Mar 2015 | - | $11.02 B(+6.7%) |
| Dec 2014 | $10.33 B(-15.3%) | $10.33 B(-3.0%) |
| Sep 2014 | - | $10.65 B(-4.7%) |
| Jun 2014 | - | $11.17 B(-5.3%) |
| Mar 2014 | - | $11.80 B(-3.2%) |
| Dec 2013 | $12.19 B(-17.2%) | $12.19 B(-3.2%) |
| Sep 2013 | - | $12.60 B(+1.1%) |
| Jun 2013 | - | $12.46 B(-1.6%) |
| Mar 2013 | - | $12.66 B(-14.0%) |
| Dec 2012 | $14.72 B(+1.4%) | $14.72 B(+6.7%) |
| Sep 2012 | - | $13.79 B(-1.8%) |
| Jun 2012 | - | $14.04 B(-3.3%) |
| Mar 2012 | - | $14.52 B(+0.0%) |
| Dec 2011 | $14.52 B(+111.0%) | $14.52 B(+77.5%) |
| Sep 2011 | - | $8.18 B(+28.2%) |
| Jun 2011 | - | $6.38 B(-5.6%) |
| Mar 2011 | - | $6.75 B(-1.8%) |
| Dec 2010 | $6.88 B(+22.6%) | $6.88 B(-3.7%) |
| Sep 2010 | - | $7.15 B(+1.9%) |
| Jun 2010 | - | $7.02 B(+14.8%) |
| Mar 2010 | - | $6.11 B(+8.9%) |
| Dec 2009 | $5.61 B(-33.5%) | $5.61 B(-13.0%) |
| Sep 2009 | - | $6.45 B(-12.9%) |
| Jun 2009 | - | $7.40 B(-18.3%) |
| Mar 2009 | - | $9.06 B(+7.3%) |
| Dec 2008 | $8.44 B(+62.7%) | $8.44 B(+81.2%) |
| Sep 2008 | - | $4.66 B(-1.9%) |
| Jun 2008 | - | $4.75 B(-11.7%) |
| Mar 2008 | - | $5.38 B(+3.7%) |
| Dec 2007 | $5.19 B(-2.6%) | $5.19 B(-2.3%) |
| Sep 2007 | - | $5.31 B(-3.5%) |
| Jun 2007 | - | $5.50 B(-0.4%) |
| Mar 2007 | - | $5.53 B(+3.8%) |
| Dec 2006 | $5.33 B(+147.9%) | $5.33 B(-1.5%) |
| Sep 2006 | - | $5.41 B(-4.1%) |
| Jun 2006 | - | $5.64 B(-0.3%) |
| Mar 2006 | - | $5.66 B(+163.3%) |
| Dec 2005 | $2.15 B | $2.15 B(+12.9%) |
| Sep 2005 | - | $1.90 B(-1.5%) |
| Jun 2005 | - | $1.93 B(-4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2005 | - | $2.02 B(-2.7%) |
| Dec 2004 | $2.07 B(+42.0%) | $2.07 B(-4.7%) |
| Sep 2004 | - | $2.17 B(-15.0%) |
| Jun 2004 | - | $2.56 B(-1.9%) |
| Mar 2004 | - | $2.61 B(+78.7%) |
| Dec 2003 | $1.46 B(-23.2%) | $1.46 B(-9.3%) |
| Sep 2003 | - | $1.61 B(+0.6%) |
| Jun 2003 | - | $1.60 B(-17.2%) |
| Mar 2003 | - | $1.93 B(+1.7%) |
| Dec 2002 | $1.90 B(+30.7%) | $1.90 B(+33.9%) |
| Sep 2002 | - | $1.42 B(-0.7%) |
| Jun 2002 | - | $1.43 B(+1.6%) |
| Mar 2002 | - | $1.41 B(-3.1%) |
| Dec 2001 | $1.45 B(+25.8%) | $1.45 B(-0.3%) |
| Sep 2001 | - | $1.46 B(+46.5%) |
| Jun 2001 | - | $994.87 M(-3.0%) |
| Mar 2001 | - | $1.03 B(-11.2%) |
| Dec 2000 | $1.16 B(+73.0%) | $1.16 B(>+9900.0%) |
| Sep 2000 | - | $0.00(-100.0%) |
| Jun 2000 | - | $882.43 M(+30.2%) |
| Mar 2000 | - | $677.91 M(+1.5%) |
| Dec 1999 | $667.68 M(+26.9%) | $667.68 M(-10.4%) |
| Sep 1999 | - | $744.90 M(+52.1%) |
| Jun 1999 | - | $489.70 M(-5.9%) |
| Mar 1999 | - | $520.40 M(-1.1%) |
| Dec 1998 | $526.20 M(+42.3%) | $526.20 M(-1.5%) |
| Sep 1998 | - | $534.40 M(+14.6%) |
| Jun 1998 | - | $466.40 M(+40.3%) |
| Mar 1998 | - | $332.40 M(-10.1%) |
| Dec 1997 | $369.70 M(-26.4%) | $369.70 M(>+9900.0%) |
| Sep 1997 | - | $0.00(0.0%) |
| Jun 1997 | - | $0.00(0.0%) |
| Mar 1997 | - | $0.00(-100.0%) |
| Dec 1996 | $502.30 M(+44.2%) | $502.30 M(>+9900.0%) |
| Sep 1996 | - | $0.00(0.0%) |
| Jun 1996 | - | $0.00(0.0%) |
| Mar 1996 | - | $0.00(-100.0%) |
| Dec 1995 | $348.40 M(+59.0%) | $348.40 M(>+9900.0%) |
| Sep 1995 | - | $0.00(0.0%) |
| Jun 1995 | - | $0.00(0.0%) |
| Mar 1995 | - | $0.00(-100.0%) |
| Dec 1994 | $219.10 M(+22.7%) | $219.10 M(>+9900.0%) |
| Sep 1994 | - | $0.00(0.0%) |
| Jun 1994 | - | $0.00(0.0%) |
| Mar 1994 | - | $0.00(-100.0%) |
| Dec 1993 | $178.60 M(+33.6%) | $178.60 M(>+9900.0%) |
| Sep 1993 | - | $0.00(0.0%) |
| Jun 1993 | - | $0.00(0.0%) |
| Mar 1993 | - | $0.00(-100.0%) |
| Dec 1992 | $133.70 M(+16.3%) | $133.70 M(>+9900.0%) |
| Sep 1992 | - | $0.00(0.0%) |
| Jun 1992 | - | $0.00(0.0%) |
| Mar 1992 | - | $0.00(-100.0%) |
| Dec 1991 | $115.00 M(-7.3%) | $115.00 M(>+9900.0%) |
| Sep 1991 | - | $0.00(0.0%) |
| Jun 1991 | - | $0.00(0.0%) |
| Mar 1991 | - | $0.00(-100.0%) |
| Dec 1990 | $124.00 M(+35.7%) | $124.00 M(>+9900.0%) |
| Sep 1990 | - | $0.00(0.0%) |
| Jun 1990 | - | $0.00(0.0%) |
| Mar 1990 | - | $0.00(-100.0%) |
| Dec 1989 | $91.40 M(+23.0%) | $91.40 M(>+9900.0%) |
| Sep 1989 | - | $0.00(0.0%) |
| Jun 1989 | - | $0.00(0.0%) |
| Mar 1989 | - | $0.00(-100.0%) |
| Dec 1988 | $74.30 M(+107.0%) | $74.30 M(>+9900.0%) |
| Sep 1988 | - | $0.00(0.0%) |
| Jun 1988 | - | $0.00(0.0%) |
| Mar 1988 | - | $0.00(0.0%) |
| Sep 1987 | - | $0.00(0.0%) |
| Jun 1987 | - | $0.00(-100.0%) |
| Mar 1987 | $35.90 M(-9.8%) | $35.90 M(>+9900.0%) |
| Dec 1986 | - | $0.00(0.0%) |
| Sep 1986 | - | $0.00(0.0%) |
| Jun 1986 | - | $0.00(-100.0%) |
| Mar 1986 | $39.80 M | $39.80 M(>+9900.0%) |
| Dec 1985 | - | $0.00(0.0%) |
| Sep 1985 | - | $0.00(0.0%) |
| Jun 1985 | - | $0.00 |
FAQ
- What is Teva Pharmaceutical Industries Limited annual total debt?
- What is the all time high annual total debt for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual total debt year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly total debt?
- What is the all time high quarterly total debt for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly total debt year-on-year change?
What is Teva Pharmaceutical Industries Limited annual total debt?
The current annual total debt of TEVA is $18.08 B
What is the all time high annual total debt for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual total debt is $35.80 B
What is Teva Pharmaceutical Industries Limited annual total debt year-on-year change?
Over the past year, TEVA annual total debt has changed by -$2.07 B (-10.29%)
What is Teva Pharmaceutical Industries Limited quarterly total debt?
The current quarterly total debt of TEVA is $18.08 B
What is the all time high quarterly total debt for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly total debt is $36.85 B
What is Teva Pharmaceutical Industries Limited quarterly total debt year-on-year change?
Over the past year, TEVA quarterly total debt has changed by $0.00 (0.00%)